BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27145925)

  • 21. c-jun/AP-1 activation does not affect the antiproliferative activity of phenethyl isothiocyanate, a cruciferous vegetable-derived cancer chemopreventive agent.
    Yao S; Zhang Y; Li J
    Mol Carcinog; 2006 Aug; 45(8):605-12. PubMed ID: 16652374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of cyclin D1-CDK4 in silica-induced transformed cells is due to activation of ERKs, JNKs/AP-1 pathway.
    Shen F; Fan X; Liu B; Jia X; Du H; You B; Ye M; Huang C; Shi X
    Toxicol Lett; 2006 Jan; 160(3):185-95. PubMed ID: 16125882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rewired ERK-JNK signaling pathways in melanoma.
    Lopez-Bergami P; Huang C; Goydos JS; Yip D; Bar-Eli M; Herlyn M; Smalley KS; Mahale A; Eroshkin A; Aaronson S; Ronai Z
    Cancer Cell; 2007 May; 11(5):447-60. PubMed ID: 17482134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transcription cofactor c-JUN mediates phenotype switching and BRAF inhibitor resistance in melanoma.
    Ramsdale R; Jorissen RN; Li FZ; Al-Obaidi S; Ward T; Sheppard KE; Bukczynska PE; Young RJ; Boyle SE; Shackleton M; Bollag G; Long GV; Tulchinsky E; Rizos H; Pearson RB; McArthur GA; Dhillon AS; Ferrao PT
    Sci Signal; 2015 Aug; 8(390):ra82. PubMed ID: 26286024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity: evidence that mitotic Bcl-2 phosphorylation is JNK-independent.
    Du L; Lyle CS; Obey TB; Gaarde WA; Muir JA; Bennett BL; Chambers TC
    J Biol Chem; 2004 Mar; 279(12):11957-66. PubMed ID: 14704147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth suppression of human mast cells expressing constitutively active c-kit receptors by JNK inhibitor SP600125.
    Wang B; Tsukada J; Higashi T; Mizobe T; Matsuura A; Mouri F; Sawamukai N; Ra C; Tanaka Y
    Genes Cells; 2006 Sep; 11(9):983-92. PubMed ID: 16923120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of c-Jun N-terminal kinase in the PDGF-induced proliferation and migration of human adipose tissue-derived mesenchymal stem cells.
    Kang YJ; Jeon ES; Song HY; Woo JS; Jung JS; Kim YK; Kim JH
    J Cell Biochem; 2005 Aug; 95(6):1135-45. PubMed ID: 15962287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription.
    Lin S; Huang HC; Chen LL; Lee CC; Huang TS
    Mol Pharmacol; 2001 Oct; 60(4):768-75. PubMed ID: 11562439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plitidepsin has a dual effect inhibiting cell cycle and inducing apoptosis via Rac1/c-Jun NH2-terminal kinase activation in human melanoma cells.
    Muñoz-Alonso MJ; González-Santiago L; Zarich N; Martínez T; Alvarez E; Rojas JM; Muñoz A
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1093-101. PubMed ID: 18089842
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel indoloquinoline derivative, IQDMA, induces G(2)/M phase arrest and apoptosis in A549 cells through JNK/p38 MAPK signaling activation.
    Su JC; Lin KL; Chien CM; Lu CM; Chen YL; Chang LS; Lin SR
    Life Sci; 2009 Sep; 85(13-14):505-16. PubMed ID: 19699753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
    Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
    J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of ERK activation involves melatonin-induced G(1) and G(2) /M phase arrest in the human osteoblastic cell line hFOB 1.19.
    Liu L; Zhu Y; Xu Y; Reiter RJ
    J Pineal Res; 2012 Aug; 53(1):60-6. PubMed ID: 21988060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.
    Albino AP; Juan G; Traganos F; Reinhart L; Connolly J; Rose DP; Darzynkiewicz Z
    Cancer Res; 2000 Aug; 60(15):4139-45. PubMed ID: 10945621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of c-Jun NH2-terminal kinase/stress-activated protein kinase (JNK/SAPK) is critical for hypoxia-induced apoptosis of human malignant melanoma.
    Kunz M; Ibrahim S; Koczan D; Thiesen HJ; Köhler HJ; Acker T; Plate KH; Ludwig S; Rapp UR; Bröcker EB; van Muijen GN; Flory E; Gross G
    Cell Growth Differ; 2001 Mar; 12(3):137-45. PubMed ID: 11306514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramide 1-phosphate stimulates macrophage proliferation through activation of the PI3-kinase/PKB, JNK and ERK1/2 pathways.
    Gangoiti P; Granado MH; Wang SW; Kong JY; Steinbrecher UP; Gómez-Muñoz A
    Cell Signal; 2008 Apr; 20(4):726-36. PubMed ID: 18234473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Helicobacter pylori and mitogen-activated protein kinases regulate the cell cycle, proliferation and apoptosis in gastric epithelial cells.
    Ding SZ; Smith MF; Goldberg JB
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e67-78. PubMed ID: 18702686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation of c-jun N-terminal kinase is associated with cell proliferation and shorter relapse-free period in superficial spreading malignant melanoma.
    Jørgensen K; Davidson B; Flørenes VA
    Mod Pathol; 2006 Nov; 19(11):1446-55. PubMed ID: 16951673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bovine type I collagen inhibits Raw264.7 cell proliferation through phosphoinositide 3-kinase- and mitogen-activated protein kinase-dependent down-regulation of cyclins D1, A and B1.
    Cho MK; Suh SH; Lee CH; Kim SG
    Biochim Biophys Acta; 2005 May; 1744(1):47-57. PubMed ID: 15878397
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Opposing Roles of JNK and p38 in Lymphangiogenesis in Melanoma.
    Puujalka E; Heinz M; Hoesel B; Friedl P; Schweighofer B; Wenzina J; Pirker C; Schmid JA; Loewe R; Wagner EF; Berger W; Petzelbauer P
    J Invest Dermatol; 2016 May; 136(5):967-977. PubMed ID: 26829032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
    Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
    Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.